Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02736344 · ClinicalTrials.gov registry record
BIONICS - Pharmacokinetics (PK) Trial
A clinical trial, sponsored by Medinol.
- Completed
- Registry status
- 12
- Enrollment target
NCT02736344 is a clinical trial that has completed, run by Medinol. The registered enrollment target is 12 participants.
The verdict
NCT02736344 has completed, sponsored by Medinol.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The BioNIR Ridaforolimus Eluting Coronary Stent System is a single use device/drug combination product comprising: * Stent - mounted Cobalt Chromium (CoCr) alloy based stent * Delivery System - Rapid Exchange (RX) Coronary System * Polymer matrix coating - Poly n-butyl methacrylate (PBMA) and polymer coating (CarboSil®) * Ridaforolimus drug - Chemical Abstracts Service (CAS) Registry Number: 572924-54-0 The product is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to lesions in vessels with reference diameters of 2.5mm to 4.25mm, including complex lesions.
Interventions
- DEVICE BioNIR Ridaforolimus Eluting Coronary Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-04 |
| Est. Completion | 2021-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02736344
The ClinicalTrials.gov registry entry for NCT02736344 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medinol, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BioNIR Ridaforolimus Eluting Coronary Stent is the first listed.
NCT02736344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02736344 about?
NCT02736344 is a clinical study titled "BIONICS - Pharmacokinetics (PK) Trial". The BioNIR Ridaforolimus Eluting Coronary Stent System is a single use device/drug combination product comprising: * Stent - mounted Cobalt Chromium (CoCr) alloy based stent * Delivery System - Rapid Exchange (RX) Coronary System * Polymer matrix coating - Poly n-butyl methacrylate (PBMA) and polym...
What is the current status of trial NCT02736344?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2016-04. Estimated completion is 2021-09.
What interventions are being tested in trial NCT02736344?
The interventions under investigation include: BioNIR Ridaforolimus Eluting Coronary Stent (DEVICE).
Who is sponsoring clinical trial NCT02736344?
This trial is sponsored by Medinol, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.